The GEROPHARM Group was included in the Russia’s Fast-Growing High-Tech Companies National Rating “TechUp” for the fifth time. The award ceremony was held on December 7 as part of the III Congress “Innovation Practice: Science plus Business”.
This year GEROPHARM entered the TOP-10 companies in the nomination “Growth Leaders”. Each year, the rating defines leaders in various business segments who are able to play a crucial role in the development and modernization of Russian industry. Over the past years, GEROPHARM has been demonstrating stable revenue growth, developing the pharmaceutical infrastructure, investing in R&D and technological innovations, and expanding its drug portfolio.
The event also announced the results of the selection of companies for participation in the priority project of the Ministry of Economic Development of the Russian Federation named “National Champions”. The GEROPHARM Group was among the 30 companies selected by the expert council. The main tool for the inclusion of companies was the “TechUp” rating.
The goal of the “National Champions” project is to ensure the rapid growth of domestic private high-tech export-oriented leading companies and the formation of multinational Russian-headquartered companies on their basis. It is assumed that the selected enterprises will be supported by the state and the development institutions, which will contribute to their achievement of the program targets by 2020.
To date, pharmaceuticals is one of the key vectors for the Russian economy development – the industry is on the rise and has great potential, both in terms of import substitution and export potential.